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ABSTRACT
Background: Smoking is a well-established risk factor for dementia, but the effects of passive smoking are
unclear. We aimed to examine links between passive smoking and dementia or cognitive impairment.
Methods: We searched seven medical research databases: MEDLINE, Web of Science (Core Collection),
Cochrane, EMBASE, PsycINFO, Scopus, and CINAHL Plus. Studies were included if they examined
measures of passive smoking and either cognitive impairment or dementia.
Results: Of 1,425 records found, nine papers of varying methodologies were included after screening against
inclusion criteria. Eight papers reported weak associations between passive smoking and either cognitive
impairment or dementia. One paper only found this association alongside carotid artery stenosis. The papers’
quality was variable, with only two deemed high quality.
Conclusion: There is limited weak observational evidence linking passive smoking with an increased risk of
cognitive impairment or dementia. However, the studies were methodologically diverse and of inconsistent
quality, preventing firm conclusions.
Key words: dementia, cognitive impairment, risk factors, environmental, passive smoking, systematic review
Introduction
Dementia is increasing in worldwide prominence
and has major public health and economic implica-
tions (Prince, 2015). Consequently, the prevention
of dementia through addressing modifiable risk
factors has become an important focus for research.
Tobacco smoking is an accepted risk for dementia
(Peters et al., 2008), through vascular damage
which is in turn linked to stroke, Alzheimer’s
disease, and other dementias. However, relatively
little is known regarding “passive” smoking and
dementia, though a recent systematic review of
environmental factors for dementia included one
article suggesting moderate evidence of an asso-
ciation with passive smoking (Killin et al., 2016).
Proposed mechanisms include vascular damage
similar to that caused by smoking, interference with
brain oxygenation, and neuroinflammation (Ghosh
et al., 2009; Ling and Heffernan, 2016).
Correspondence should be addressed to: Dr Lucy E. Stirland, Centre for
Dementia Prevention, University of Edinburgh, Kennedy Tower, Royal
Edinburgh Hospital, Edinburgh EH10 5HF, UK. Phone: +0044-131-537-
6257. Email: l.stirland@ed.ac.uk. Received 16 Aug 2017; revision requested
19 Oct 2017; revised version received 10 Nov 2017; accepted 13 Nov 2017.
Some of the existing literature refers to “cog-
nitive impairment,” a term which can encompass
a variety of clinical syndromes including Mild
Cognitive Impairment and static deficits.
There have been no literature reviews to date on
the links between passive smoking and dementia in
adults. We, therefore, present the first systematic
review on the association between passive smoking
and both dementia and cognitive impairment.
Methods
Information sources
Two reviewers conducted a search of seven online
databases: MEDLINE, Web of Science (Core Col-
lection), Cochrane, EMBASE, PsycINFO, Scopus,
and CINAHL Plus on 10th December 2014.
Search
“Passive” smoking is also referred to as “second-
hand smoke,” “environmental tobacco exposure,”
or “involuntary smoking.” Its definition normally
includes both smoke exhaled by a nearby smoker
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and “side-stream” smoke released into the envir-
onment by lit cigarettes or other smoked tobacco
(McKenzie et al., 2014). Therefore, our search
terms included combinations of keywords for pass-
ive smoking (passive, second-hand, environmental,
and involuntary smoking) and dementia, cognitive
impairment, cognitive function, or Alzheimer’s dis-
ease. Full search terms are in Appendix A1, avail-
able as supplementary material online attached to
the electronic version of this paper at http:/journals.
cambridge.org/ipg. Anticipating the field of re-
search to be small, we intentionally kept our search
terms broad and inclusive. We included studies
with cognitive impairment or dementia as the
outcome of interest and set no age limit in adults.
We augmented this search by tracking citations
of each of the papers using Google Scholar, and
examining the bibliographies of each paper for
relevant titles.
Study selection and eligibility criteria
Two reviewers independently screened the emer-
gent titles against inclusion and exclusion criteria
and produced a list of abstracts, which were further
assessed for relevance before obtaining the full
articles for selected records. The inclusion criteria
specified that papers must contain measures of
both exposure to passive smoking and cognitive
function or dementia. Both longitudinal and
cross-sectional studies were included. Papers were
excluded if they examined cognitive impairment in
children, current smokers only, or passive smoking
among smokers. Non-English language articles
were also excluded, as were non-human studies.
Papers consisting solely of systematic review were
excluded.
Data collection process
Having gathered our list of included papers
two authors (LS, CO) independently used a
standardized data extraction form to collect key
process and outcome data. We collated these
summary data and resolved any disagreements.
Risk of bias within and between studies
We created a tailored quality assessment tool with
the aim of detecting selection bias, confounding,
and information bias (Hammer et al., 2009). For
example, we looked for clearly defined outcomes
measured using objective criteria. Using this tool,
we separately assessed each paper’s quality and
risk of bias before agreeing together a final overall
quality score: high, satisfactory, or low. High quality
papers were considered to have little or no risk of
bias and to contain objective measures of cognitive
function and passive smoking. Satisfactory quality
Table 1. Databases searched
year number
database of titles
database started found
........................................................................................................................................................
MEDLINE 1946 114
Web of Science
(Core
Collection)
1900 25
Cochrane 1993 34
EMBASE 1980 150
PsycINFO 1806 23
Scopus 1970 1,005
CINAHL Plus 1937 74
was defined as showing some suggestion of flaws in
the study which could lead to a risk of bias. Low
quality papers were considered to have significant
flaws in key aspects of study design which could
bias the results.
We aimed to assess publication bias if possible.
We excluded papers which duplicated work
published elsewhere, for example articles reporting
similar analyses within a single dataset or cohort.
Registration
This review was prospectively registered with the
University of York’s Centre for Reviews and Dis-
semination PROSPERO register on 22nd Septem-
ber 2014 (record number CRD42014013543).
Ethical approval was not sought as we did not
conduct any primary research.
Results
Study selection
Our search identified a total of 1,425 records from
the databases listed in Table 1. Figure 1 depicts
a PRISMA diagram summarizing the search,
screening, and selection process. No additional
papers were identified through citation tracking and
bibliography searching. After removal of duplicates,
35 titles met the inclusion criteria. These abstracts
were then screened for eligibility and 26 excluded,
for reasons stated in Figure 1.
Synthesis of results
The studies differed in their methodology, reported
outcomes, and statistical methods. We considered
the possibility of meta-analysis and found it would
not be appropriate to pool data for this reason
(The Cochrane Collaboration, 2011). A summary
of our rationale in Appendix A2, available as
supplementary material online attached to the
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1425 records identified 
through database searching 
0 records identified 
through citation tracking 
and reference searching 
108 titles met inclusion criteria 73 duplicates removed 
35 abstracts screened for 
eligibility 
26 articles excluded: 
11 editorials  
5 conference abstracts of research published 
elsewhere 
4 papers included no measure of passive smoking 
2 review articles  
2 irrelevant papers  
1 paper duplicated research published elsewhere 
1 included no measure of cognitive function 
9 full-text articles included in 
qualitative analysis  
Figure 1. PRISMA flow diagram of systematic review search process.
electronic version of this paper at http:/journals.
cambridge.org/ipg. We have summarized each
paper’s methods, findings, and our overall quality
ratings in Table 2.
Study characteristics
Nine papers were included in the final analysis,
four of which reported research conducted in China
(Chen, 2012; Chen et al., 2012; 2013a; 2013b),
two in the UK (Llewellyn et al., 2009; Heffernan
and O’Neill, 2013), two in the USA (Barnes
et al., 2010; Akhtar et al., 2013), and one in
Italy (Orsitto et al., 2012). They comprised seven
cross-sectional studies, one between-groups design,
and one longitudinal study. One paper presented
a systematic literature review alongside new study
data (Chen et al., 2013a).
All studies included standard cognitive tests and
justified their use. Three studies also included
clinical interview to verify diagnoses of dementia or
the presence of cognitive impairment (Barnes et al.,
2010; Chen, 2012; Orsitto et al., 2012). One paper
included both a standardized test and self-reported
functional limitation from memory impairment
(Akhtar et al., 2013). Four studies (Barnes et al.,
2010; Chen, 2012; Chen et al., 2012; 2013b)
referred to dementia as a measured outcome,
one included both dementia and Mild Cognitive
Impairment (Orsitto et al., 2012), another three fo-
cused on general cognitive impairment (Llewellyn
et al., 2009; Akhtar et al., 2013; Chen et al., 2013a),
and one paper specifically examined prospective
memory (Heffernan and O’Neill, 2013).
To quantify exposure to passive smoking, two
studies measured levels of cotinine, a metabolite of
nicotine, which is an accepted biological marker of
exposure to cigarette smoke (Llewellyn et al., 2009;
Akhtar et al., 2013). The remaining seven studies
relied on self-report using different structured
interview templates. No studies used a combination
of biomarker and self-report.
Six papers reported an association between
increased levels of passive smoking and a form
of cognitive impairment (Llewellyn et al., 2009;
Chen et al., 2012; Orsitto et al., 2012; Akhtar
et al., 2013; Chen et al., 2013a; Heffernan
and O’Neill, 2013). Two papers described an
association between passive smoking and dementia
(Chen, 2012; 2013b). One paper reported no
association between passive smoking alone and
dementia, but found an association in a sub-group
analysis of people with greater than 25 years’ of
exposure to passive smoking and more than 25%
carotid artery stenosis (Barnes et al., 2010).
Discussion
Most papers reported an association between
passive smoking and either cognitive impairment
or dementia. However, overall there was a paucity
of evidence and the majority of studies were at
moderate risk of bias. In particular, all of the
studies specifically examining dementia were only
of satisfactory quality, and the highest quality
research was limited to cognitive impairment. The
papers’ methodological heterogeneity prevented
meta-analysis so we did not find convincing
evidence of any associations.
Recent interest in this topic is reflected in the fact
that all the papers identified were published since
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Table 2. Synthesized summary of papers reporting the association between exposure to passive smoking and cognitive impairment or dementia
methodology measurement measurement
and sample of passive of cognitive confounders significant quality
study location description smoking functioning measured findings score
.......................................................................................................................................................................................................................................................................................................................................................................................................................................................
Akhtar et al.
(2013)
Cross-sectional.
Community-
based sample in
USA.
n = 2,452
non-smokers
aged ≥ 60,
1,489 exposed
to passive
smoke∗ baseline
rate of dementia
not given.
Defined as serum
cotinine level 0.011–
9.53 ng/mL.
DSST, self-reported
functional limitation
due to confusion and
memory problems.
Age, race/ethnicity,
gender, education,
diabetes,
hypertension, BMI,
stroke, heart attack,
and alcohol use.
Cotinine level had no
significant association
with self-reported
confusion and memory
problems. Minimally
adjusted linear regression
(95% CI) of cotinine level
in people who had never
smoked was associated
with a change in DSST
score by −2.03 (−3.00,
−1.05). When fully
adjusted the change in
DSST score was −1.17
(−2.32, −0.02).
H
Llewellyn
et al.
(2009)
Cross-sectional.
Community-
based sample in
England.
n = 4,809. Mean
age 65.
Proportion
exposed to
passive smoke
not given. A
total of 481
cognitively
impaired at
baseline.
Defined as salivary
cotinine level
0.0–14.1 ng/ml, split
into fourths.
Composite scores on:
Letter Cancellation
Task, MMSE (time
orientated questions),
Health and
Retirement Study 10
Word Learning Task,
Prospective Memory
Tasks, and simple
calculations,
CAMCOG -
Semantic Verbal
Fluency. Cognitive
impairment defined as
lowest 10% of
summarized scores.
Several models of
adjustment. Fully
adjusted model: age,
sex, education, testing
interval, ethnicity,
manual occupation,
net wealth, smoking
history, obesity,
alcohol consumption,
physical inactivity,
depressive symptoms,
and medical
conditions (diabetes,
cardiovascular
disease, stroke,
treated, and untreated
hypertension).
Compared with lowest
fourth of cotinine
concentration (0.0–0.1
ng/mL), multi-variable
adjusted odds ratios (95%
CI) for cognitive
impairment in the highest
fourth (0.8–13.5 ng/mL)
was 1.70 (1.03, 2.80)
among never smokers.
Associations between
lower cotinine levels and
cognitive impairment
were non-significant. In
the fully adjusted model,
there was a significant
trend of cognitive
impairment with
increasing cotinine
concentration (p for trend
0.025).
H
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Table 2. Continued
measurement measurement
methodology sample of passive of cognitive confounders significant quality
study and location description smoking functioning measured findings score
.......................................................................................................................................................................................................................................................................................................................................................................................................................................................
Barnes et al.
(2010)
Longitudinal.
Four
communities in
USA.
n = 970 never
smokers with
no baseline
cardiovascular
disease, mean
age 74. A total
of 500 lived
with a smoker,
none had
dementia
diagnosis at
baseline.
Self-report. Number of
years living with
smoker, categorized
into three levels of
exposure.
Follow-up at mean
5.5 years to assess
progression to
dementia. Dementia
diagnosis made by
multi-professional
adjudication
committee based on
cognitive tests scores
(Modified MMSE),
hospital records, ADL
ability, and other
clinical factors.
Age, race, gender,
income, education,
Apolipoprotein-E
genotype, CRP,
occupation,
self-reported health,
hypertension,
diabetes, physical
activity, depression,
weight, cholesterol,
and alcohol intake.
Using Cox proportional
hazards with marginal
structural models, there
was no evidence of
association between SHS
exposure alone and
dementia. Adjusted
hazard ratio (95% CI) of
dementia with >25 years’
SHS exposure and >25%
carotid artery stenosis was
3 (1.03, 9.72).
S
Chen
(2012)
Cross-sectional.
Four separate
urban and rural
areas in China
(Four province
study).
n = 2,692 never
smokers, mean
age 72, 810
exposed to
passive smoke
49 had
dementia
syndrome at
baseline.
Self-report. Split into
“none at all;” “yes,
some,” and “yes, a
lot” for three different
environments;
reported years of
exposure.
GMS-AGECAT,
Modified CERAD,
and CSI-D. Those
with scores in the top
15% were interviewed
clinically to establish
diagnosis.
Age, sex, urban/rural
location, education
level, occupation,
income, marital
status, religion,
current drinking,
visiting children or
relatives, head
injuries, COPD,
hypertension, and
stroke.
Multivariable Cox-adjusted
Risk Ratio (95% CI) for
all dementia was 1.78
(1.18, 2.69). Increased
exposure at home led to
further increased risk.
S
Chen et al.
(2012)
(Research
Letter)
Cross-sectional.
Four separate
urban and rural
areas in China
(Four province
study, women
only)
n = 1,979 female
never smokers
aged ≥60. A
total of 635
exposed to
passive smoke,
174 had
dementia
syndrome at
baseline.
Self-report. Split into
“none at all;” “yes,
some,” and “yes, a
lot” for three different
environments;
reported years of
exposure.
GMS-AGECAT; case
level score ≥3. Scores
1 and 2 labelled
“subcases.”
Age, province,
urban/rural location,
educational level,
occupation, marital
status, COPD, head
injuries, hypertension,
and stroke.
Multivariable Cox-adjusted
Risk Ratio (95% CI) for
cognitive impairment with
SHS exposure 1.39 (1.01,
1.89), increasing with
self-reported dose and
duration. No association
found between exposure
to SHS and subcases.
S
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Table 2. Continued
measurement measurement
methodology sample of passive of cognitive confounders significant quality
study and location description smoking functioning measured findings score
.......................................................................................................................................................................................................................................................................................................................................................................................................................................................
Chen et al.
(2013a)
Cross-sectional.
Rural and
urban areas in
China (third
wave of Anhui
study).
n = 1,081 never
smokers, mean
age 76, 350
exposed to
passive smoke,
166 cases of
dementia at
baseline.
Self-report. Split into
“none at all;” “yes,
some,” and “yes, a
lot” for three different
environments;
reported years of
exposure.
GMS-AGECAT;
case-level score ≥3.
Age, sex, BMI,
urban/rural location,
education level,
occupational class,
marital status,
religion, head injury,
hypertension,
diabetes, stroke,
COPD, fish and
vegetable
consumption
Multivariable adjusted Risk
Ratio (95% CI) for
cognitive impairment was
statistically significant
when cumulative years of
exposure was ≥50 (RR
1.82, 95% CI 1.20, 2.76),
increasing with dose and
duration.
S
Chen et al.
(2013b)
Cross-sectional.
Five separate
urban and rural
areas in China
(combination of
four province
study and third
wave of Anhui
study).
n = 5,921. Mean
age 73. A total
of 2,153
exposed to
passive smoke,
and 626 had
dementia
syndrome at
baseline.
Self-report as “none at
all;” “yes, some,” and
“yes, a lot” for three
different
environments;
reported years of
exposure.
GMS-AGECAT;
case-level score ≥3
defined as “severe
dementia syndrome”
(scores 1 and 2
defined as “moderate
dementia syndrome”).
Age, sex, urban/rural
location, education
level, occupation,
smoking status,
income, marital
status, religion,
current drinking,
visiting children or
relatives,
hypertension, stroke,
and depressive
syndrome.
Multivariable adjusted Risk
Ratio (95% CI) for
“severe dementia” with
SHS exposure in never
smokers 1.33 (1.01, 1.74)
increasing with
self-reported dose and
duration. No association
between exposure to SHS
and “moderate dementia
syndrome.”
S
Orsitto et al.
(2012)
Cross-sectional.
Inpatients in
geriatric ward,
Italy.
n = 933, mean
age 77, 96
exposed to
passive smoke.
A total of 124
had dementia at
baseline.
Self-report. Structured
questionnaire from
patient or relative.
Number of hours of
smoke exposure in
past seven days.
MMSE, CDR.
Dementia and MCI
diagnoses made
clinically according to
international
diagnostic criteria.
Age, educational level,
and smoking history.
Multivariable-adjusted odds
ratio (95% CI) for MCI in
those exposed to SHS
compared to dementia 2.7
(1.5, 4.4) and compared
to cognitively intact
individuals 1.9 (1.0, 3.5).
S
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Table 2. Continued
measurement measurement
methodology sample of passive of cognitive confounders significant quality
study and location description smoking functioning measured findings score
.......................................................................................................................................................................................................................................................................................................................................................................................................................................................
Heffernan
and
O’Neill
(2013)
Between-Groups
Design.
Psychology
laboratory,
England.
n = 79 students,
mean age 23. A
total of 24 were
exposed to
passive smoke,
none had
baseline
cognitive
impairment.
Divided into
groups: current
smokers,
non-smokers
exposed to
SHS, and
non-smokers
not exposed to
SHS.
Self-report
questionnaire:
number of hours
exposed to SHS per
week.
CAMPROMPT Age, alcohol
consumption, HADS
anxiety and
depression score, and
NART score.
ANCOVA analysis. There
were significant
differences between
groups on the
CAMPROMPT test, with
the non-SHS group
recalling significantly
more time-based tasks
than the SHS group (p <
0.001).
L
∗ = passive smoking taken as any detectable serum cotinine.
Quality scores: H = high, S = satisfactory, and L = low.
DSST = Digit Symbol Substitution Test.
BMI = Body Mass Index.
MMSE = Mini Mental State Examination.
CAMCOG = Cambridge Cognitive Examination.
SHS = Second-hand smoke.
CRP = C-reactive protein.
GMS-AGECAT = Geriatric Mental Status – Automated Geriatric Examination for Computer Assisted Taxonomy.
CERAD = Consortium to Establish a Registry for Alzheimer’s Disease.
CSI-D = Community Screening Instrument for Dementia.
COPD = Chronic obstructive pulmonary disease.
CDR = Clinical Dementia Rating Scale.
CI = Confidence interval.
MCI = Mild cognitive impairment.
CAMPROMPT = Cambridge Prospective Memory Test.
HADS = Hospital Anxiety and Depression Score.
NART = National Adult Reading Test.
ANCOVA = Analysis of covariance.
PM = Prospective memory.
ADL = Activities of Daily Living.
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2009, which complements contemporary research
into the links between air pollution and dementia
(Weuve et al., 2012; Killin et al., 2016; Chen et al.,
2017).
Comparison with other literature
To our knowledge, there is only one other
systematic review on the topic of passive smoking
and cognitive impairment, presented in a 2013
paper alongside novel study data (Chen et al.,
2013a). It excluded studies where the endpoint
was dementia on the questionable basis that
this differs pathologically and prognostically from
cognitive impairment. It used a lower age limit
of 60 years and therefore only reviewed three
papers. Therefore, ours is the first comprehensive
systematic review of the associations between
passive smoking and both dementia and cognitive
impairment.
Strengths and limitations
Our review sought to be comprehensive by using
broad search terms in multiple databases with
no age limits in adults; this is reflected in the
wide range of records returned by the search.
The fact that no papers were found using citation
tracking or bibliography searching provides further
evidence suggesting that our search method was
exhaustive. We included studies reporting both
dementia and cognitive impairment, which is a
term used inconsistently to describe a variety of
clinical states. There is a lack of standardized
quality assessment tools for systematic reviews of
this type. We, therefore, created our own quality
assessment tool structured around common causes
of bias and based on existing guidelines for
evaluating cohort studies (Hammer et al., 2009;
Scottish Intercollegiate Guideline Network, 2012).
Our restriction to English-language publications
may have led to the exclusion of potentially relevant
research findings in other languages. Although
the databases we searched were predominantly
in English, some papers in other languages were
excluded at the title screening stage.
Overall, because outcome measures differed, it
was impossible to directly compare the strengths
of association between studies and to quantitatively
meta-analyze the results. Therefore, conclusions
from our review are limited to general observations
on cognitive test results or diagnostic outcomes.
Measurement of passive smoking
A number of studies identified passive smoking
through self-reporting which is open to criticism.
In the studies based in China, high illiteracy rates
(reported as 61% in one paper (Chen et al., 2013a))
may have influenced participants’ answers to the
question “have you experienced passive smoking”?
The author goes on to explain that “most Chinese
people are unaware of the health hazards of either
active or passive smoking,” with only 32% of people
understanding that exposure to passive smoking
carries health risks. Furthermore, there was
variation between the papers’ implied definitions
of exposure to passive smoking. For example,
one paper included structured questionnaires with
more detail about exposure to cigarette smoke in
different environments but this only applied to the
last seven days (Orsitto et al., 2012). Conversely,
another study asked participants about exposure
to cigarette smoke at home across the lifespan.
However, this study did not include workplace or
other sources of second-hand smoke (Barnes et al.,
2010). This variation in measurement of passive
smoking was one of the factors limiting our ability
to meta-analyze all the studies’ findings.
Two papers used cotinine levels as a biomarker
for passive smoking. Cotinine has a half-life of
15–19 hours (Benowitz, 1996), which means that
cross-sectional measurement of this only reflects
exposure to second-hand smoke within recent days.
If passive smoking were considered a risk factor
for a chronic neurodegenerative disease such as
dementia, care should be taken not to infer lifetime
exposure from a single biomarker measurement and
repeated measures would be likely to give a more
accurate estimate of actual exposure. Given that the
neuropathological processes underlying dementia
are present long before the onset of symptoms
(Price and Morris, 1999), it would be intuitive to
combine both biomarkers of recent exposure and
self-reported historical exposure. This method is
suggested as the most reliable measure of passive
smoking (Pérez-Ríos et al., 2013) and we would
recommend it be used in future studies.
Measurement of cognitive impairment and
dementia
Four of the nine included papers were by the same
first author and sampled different combinations
of study participants from the same two cohorts.
All of these papers identified cognitive impairment
using the GMS-AGECAT algorithm. However,
there were variations in how the categories were
interpreted across the studies. For example, a score
of 3 or more was defined as a “severe dementia
syndrome” in one study (Chen et al., 2013b) and
as “caseness” in others (Chen et al., 2012; 2013a).
Severe dementia suggests a different clinical picture
than mere “caseness” and this inconsistency could
lead to difficulty in interpreting these results and
applying them in clinical practice.
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The outcome measures for cognitive function
across the studies varied. In the papers exploring
general cognitive impairment rather than dementia,
outcomes included several different neuropsycho-
logical tests, with or without clinical assessment
and participants’ subjective experience of memory
loss. One study used a prospective memory test,
which may be less relevant to clinical dementia
assessment (Heffernan and O’Neill, 2013). Only
one paper specifically investigated Mild Cognitive
Impairment as an outcome but its cross-sectional
design did not allow for measuring progression
to dementia (Orsitto et al., 2012). The three
papers where dementia was the outcome also had
diverse outcomes, with one including scores on
a cognitive test alone, one adding an unspecified
clinical interview procedure, and the third one
combining a cognitive test and the opinion of a
multi-professional adjudication committee.
Risk of bias within and between studies
None of the studies included or mentioned
power calculations. Most of the studies were
of relatively large cohorts and the analyses may
have been adequately powered but this was not
formally discussed in the papers. None of the
papers mentioned whether raters were blinded
when deciding outcomes. In cases where a
clinical diagnosis was made, no papers included
clarification of whether this was repeated by a
second professional.
Publication bias suggests that studies finding
positive associations are more likely to be pub-
lished. This could have led to the disproportionate
representation of positive results in the literature we
found (Guyatt et al., 2011). The diversity of the
papers’ outcomes and statistical methods prevented
us from calculating publication bias or preparing a
funnel plot.
A potential source of confounding is the smoking
history of participants. All studies acknowledged
this but accounted for it in different ways, either
by excluding former smokers, analyzing them
separately or adjusting for smoking history in their
analyses. In addition, people exposed to passive
smoking may share lifestyle factors with smokers,
adding further potential confounding (Koo et al.,
1997). Four studies adjusted for alcohol intake, two
considered physical activity, and one referred to
specific dietary factors.
Four of the nine papers studied combinations
of participants from two cohort studies. These did
not meet our exclusion criteria because each paper
studied a different subset with some variation in
methods and were not strictly duplications. We
included and discussed all of these for transparency.
One of the papers (Chen et al., 2013b) contained
participants which all appeared in three of the
other papers (Chen, 2012; Chen et al., 2012;
2013a). There is, therefore, overlap between
participants analyzed. This is a major source of
bias and, given the relatively small field of research,
affects the overall generalizability of the work we
reviewed.
In the analysis of some studies’ results, ordinal
data were used to make numerical calculations.
This involved passive smoking being categorized as
“no, none at all,” “yes, some,” or “yes, a lot” and
each of these groups being allocated an “exposure
level” number, 0, 1, or 2. The number of self-
reported years of exposure to second-hand smoke
was then multiplied by these “exposure levels” to
give what the authors called a cumulative dose. The
authors then performed calculations that inferred
an increasing risk of dementia syndromes with
increasing cumulative dose (Chen, 2012; Chen
et al., 2012; 2013a; 2013b). Calculating risk and
odds ratios using ordinal data in this manner could
be seen as introducing analytical bias and confers a
significant limitation to the affected studies.
Our broad search strategy led to the inclusion of
a study assessing the association of passive smoke
on changes in prospective memory in a sample of
undergraduate students (Heffernan and O’Neill,
2013). There was a limitation in this study, which
may make interpretation of its findings difficult. Its
exclusion criteria included “drinking in excess of
UK Government guidelines for safe drinking” but
the mean alcohol consumption across the groups
studied was 30–34 units per week. At the time
of the paper’s publication, this level of intake
exceeded UK Government recommendations on
sensible drinking (Department of Health, 2007).
We corresponded with the author who explained
that reference to this exclusion criterion was
an error. In addition, the exclusion criteria
included participants who had a current psychiatric
condition. However, the mean Hospital Anxiety
and Depression Scale (HADS) scores of the
second-hand smoke group was 9.62 which is a
borderline abnormal result, which could indicate
abnormal levels of anxiety and depression, a
potentially important confounding factor.
Potential mechanisms
All the studies we included were observational
and therefore, cannot be used to infer causality;
the possibility of residual confounding remains.
However, evidence from animal and human
studies supports a mechanistic link between
tobacco smoking and cognitive impairment and
dementia, probably due to microglial activation and
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neuroinflammation (Ghosh et al., 2009; Moreno-
Gonzalez et al., 2013). Passive smoking is
considered a risk factor for other diseases such
as stroke and cardiovascular disease because it
causes vascular changes common to those caused
by smoking (Glantz and Parmley, 1995; Jefferis
et al., 2010). These vascular effects are possible
mechanisms to explain links between passive
smoking and dementia or cognitive impairment in
later life (Ling and Heffernan, 2016).
There is some evidence to suggest a link between
exposure to passive smoking and poorer cognitive
outcomes in children and adolescents (Yolton et al.,
2005). Speculative hypotheses for why this might be
the case include the effect of carbon monoxide from
tobacco smoke interfering with brain oxygenation
(Ling and Heffernan, 2016). There is also evidence
from mouse models that procarcinogens in tobacco
smoke cause neuroinflammation, particularly in the
hippocampus, which is responsible for aspects of
learning and memory (Ghosh et al., 2009).
Other possible explanations for the associations
found could be confounding factors, which have
not yet been identified as risk factors for dementia
and were therefore not accounted for. Only two of
the papers we reviewed were graded as high quality,
defined as having little or no risk of bias. Therefore,
this may also have contributed to the direction of
overall findings.
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